The Lab-Grown Solution to Coffee's Climate Crisis
Arabica makes up 60% of global coffee production and commands premium prices for a reason: its complex fruit notes, delicate acidity, and aromatic depth define what specialty coffee tastes like. The problem is that Arabica is fragile. Rising temperatures could slash suitable growing areas by half by 2050. Disease losses already claim 26% of global production annually.
Robusta, meanwhile, thrives in hotter climates, shrugs off pests, and yields more per hectare. Its bitter, rubbery profile keeps it relegated to instant coffee and cheap blends. Coffee’s existential question has always been: why can’t we have both?
A Paris-based startup called Amatera thinks it’s found the answer—and has just closed a €6 million seed round to prove it.
Robustica: The Best of Both
Amatera is developing what it calls “Robustica,” a variety engineered to combine Robusta’s climate resilience and higher yields with Arabica’s flavour complexity. The company’s co-founder and CEO, Omar Dekkiche, puts the urgency plainly: “Coffee is under threat, but today it can take more than 20 years to create a new coffee variety.”
The seed round was co-led by Demea Sustainable Investment and Oyster Bay Venture Capital, with participation from Paulig’s venture arm PINC, Exceptional Ventures, Mudcake, and AgFunder. Dekkiche and his co-founder Dr. Lucie Kriegshauser met through Entrepreneur First and launched Amatera in 2022.
Accelerating Nature Without GMO
What sets Amatera apart is its method. Rather than gene editing or traditional field breeding—which requires growing thousands of plants over decades—the company works at the cellular level.
Their process uses plant cell culture combined with robotics and AI. Scientists induce spontaneous genetic variation through physical and chemical triggers, then screen thousands of cellular lines for desirable traits before regenerating any plants. Known genetic markers help identify which cells will produce disease resistance, heat tolerance, or—critically for Robusta—lower bitterness.
“We are non-GMO and we don’t need to get regulatory approvals,” Dekkiche explained. By the time a cell line reaches the nursery, researchers already know what traits the mature plant will express.
The company claims its approach is twice as fast and ten times more cost-effective than conventional breeding programmes.
A Naturally Caffeine-Free Arabica
Beyond Robustica, Amatera is also developing a naturally caffeine-free Arabica variety. Unlike conventional decaf, which relies on solvent processes or supercritical CO2 to strip caffeine after harvest, a naturally caffeine-free bean would eliminate that step entirely. The result: a decaf that retains more of the origin’s character, without the processing overhead.
Why This Matters
The maths are stark. Global coffee consumption is expected to double by 2050. Rising temperatures are already pushing production uphill in Ethiopia, Colombia, and Central America—but there’s only so much mountain left. Specialty roasters depend on terroir-driven beans from established growing regions, and climate volatility threatens that supply chain.
Variety innovation has historically been slow. Coffee breeding programmes at institutions like World Coffee Research take decades to bring new cultivars to market. Amatera is betting that cell-stage screening can compress those timelines dramatically.
The company expects first production by 2027, with plans to license varieties to coffee trading houses or develop them in partnership with major food companies. If Robustica delivers on its promise—Arabica’s cup profile, Robusta’s growing range—it could reshape which origins remain viable as the planet warms.
For specialty coffee drinkers who care about single-origin transparency and terroir, that’s both a challenge and an opportunity. The question isn’t whether coffee production will change, but whether breeders can keep pace.